Literature DB >> 2626036

Effect of steroids and antisteroids on human meningioma cells in primary culture.

M A Blankenstein1, C van der Meulen-Dijk, J H Thijssen.   

Abstract

Human meningiomas are rich in progestin receptors but virtually devoid of oestrogen receptors. We have studied the hormonal sensitivity of meningioma cells in vitro during 8 days of primary culture in the presence of different steroids and antisteroids. On day 8 the thymidine labelling index (TLI) was determined as a measure of cell growth. To date 30 cultures have been established from 39 tissue specimens. 13 cultures had a TLI below 1.0 and their growth were not affected by hormones. The TLI of the other 17 cultures was 3.0 +/- 1.7 (mean +/- SD; range 1.2-7.7). Following culture in the presence of 1 and 10 nM progesterone TLI was 83 +/- 28% (n = 9) and 61 +/- 29% (n = 3) of that of the control cultures respectively. Although in individual cultures occasional differences were found, the overall values are not statistically different from 100. Similarly, 1 nM of oestradiol and testosterone had no effect on the TLI (n = 3). Tamoxifen at 1 nM increased the TLI to 138% in one culture and decreased it to 66% of the control in another. The antiprogestin mifepristone (RU 486) in concentrations of 0.1, 1.0, 10, 100 and 1000 nM decreased the TLI to 72 +/- 30; 54 +/- 20; 55 +/- 20; 59 +/- 18 and 65 +/- 10 respectively (n = 6-15; P less than 0.05 vs control). It is concluded that although a growth promoting effect of progestins on meningioma could not be shown, the therapeutic possibilities of antiprogestins warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2626036     DOI: 10.1016/0022-4731(89)90119-2

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  6 in total

Review 1.  Orbital meningiomas: surgery, radiotherapy, or hormones?

Authors:  G E Rose
Journal:  Br J Ophthalmol       Date:  1993-05       Impact factor: 4.638

2.  A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study.

Authors:  J W Goodwin; J Crowley; H J Eyre; B Stafford; K A Jaeckle; J J Townsend
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

3.  Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.

Authors:  Stefan Wolfsberger; Soroush Doostkam; Hans-Gerd Boecher-Schwarz; Karl Roessler; Michael van Trotsenburg; Johannes A Hainfellner; Engelbert Knosp
Journal:  Neurosurg Rev       Date:  2004-05-27       Impact factor: 3.042

Review 4.  The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature.

Authors:  Giulia Cossu; Marc Levivier; Roy Thomas Daniel; Mahmoud Messerer
Journal:  Biomed Res Int       Date:  2015-06-03       Impact factor: 3.411

5.  A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.

Authors:  Keng Siang Lee; John J Y Zhang; Ramez Kirollos; Thomas Santarius; Vincent Diong Weng Nga; Tseng Tsai Yeo
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

6.  Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis.

Authors:  Laura Dresser; Ryan T Merrell; David Olayinka Kamson; Carlen Amy Yuen; Andrew Wilmington; Matthew Walker; Tilley Jenkins Vogel
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.